IGF1R is a transmembrane tyrosine kinase receptor and considered as a potential therapeutic target due to associations of IGF1R overexpression with tumor metastasis, drug resistance, and poor prognosis in multiple cancer types [14,15,16,17]. The gene discussed is IGF1R; the disease is neoplasm.